PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Exclusive Interview with PharmaShots: Jeremiah Robison of Cionic Shares Insight on Neural Sleeve for Neurological Disorders

Exclusive Interview with PharmaShots: Jeremiah Robison of Cionic Shares Insight on Neural Sleeve for Neurological Disorders

March 30, 2022

Antengene’s Eltanexor (ATG-016) Receive the NMPA’s IND Approval for P-II Study to Treat Patients with High-Risk Myelodysplastic Syndromes

Antengene’s Eltanexor (ATG-016) Receive the NMPA’s IND Approval for P-II Study to Treat Patients with High-Risk Myelodysplastic Sy...

March 30, 2022

Fresenius Kabi’s Stimufend (biosimilar, pegfilgrastim) Receives EC’s Approval for Oncology Indications

Fresenius Kabi’s Stimufend (biosimilar, pegfilgrastim) Receives EC’s Approval for Oncology Indications

March 30, 2022

Ocuphire Reports Results of Nyxol in P-III (MIRA-3) Registration Trial for the Reversal of Pharmacologically-Induced Mydriasis

Ocuphire Reports Results of Nyxol in P-III (MIRA-3) Registration Trial for the Reversal of Pharmacologically-Induced Mydriasis

March 30, 2022

ViiV Healthcare’s Cabenuva (cabotegravir, rilpivirine) Receives the US FDA’s Approval for Virologically Suppressed Adolescents with HIV

ViiV Healthcare’s Cabenuva (cabotegravir, rilpivirine) Receives the US FDA’s Approval for Virologically Suppressed Adolescents wit...

March 30, 2022

Pfizer Report Results of Etrasimod in P-III (ELEVATE UC 52) Study for the Treatment of Ulcerative Colitis

Pfizer Report Results of Etrasimod in P-III (ELEVATE UC 52) Study for the Treatment of Ulcerative Colitis

March 30, 2022

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us